HIGHLIGHTS
- who: Rania Zekry from the DepartmentDamanhour University have published the Article: Comparative study of Dapagliflozin versus Glimepiride effect on insulin regulated aminopeptidase (IRAP) and interleukin-34 (IL-34) in patient with type 2 diabetes mellitus, in the Journal: Scientific Reports Scientific Reports
- what: Both glimepiride or dapagliflozin significantly improved glycemic control, insulin resistance (as indicated by HOMA-IR), and NT-proBNP with no significant difference between them in type 2 diabetic patients.
SUMMARY
This study aims to compare the effect of dapagliflozin versus glimepiride on glycemic control, HOMA-IR, and on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.